Short Interest in Moolec Science SA (NASDAQ:MLEC) Drops By 48.9%

Moolec Science SA (NASDAQ:MLEC) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totaling 9,414 shares, a decrease of 48.9% from the June 30th total of 18,435 shares. Currently, 1.6% of the shares of the company are sold short. Based on an average trading volume of 4,381 shares, the days-to-cover ratio is currently 2.1 days.

Moolec Science Stock Performance

MLEC stock traded down $0.26 during mid-day trading on Tuesday, reaching $7.10. The company had a trading volume of 4,192 shares, compared to its average volume of 703,744. Moolec Science has a one year low of $3.08 and a one year high of $53.40. The stock has a market capitalization of $5.18 million, a P/E ratio of -0.22 and a beta of 0.26. The company has a quick ratio of 0.08, a current ratio of 0.15 and a debt-to-equity ratio of 0.79. The stock’s 50-day simple moving average is $7.50 and its two-hundred day simple moving average is $7.99.

Moolec Science (NASDAQ:MLEC) last released its quarterly earnings data on Thursday, May 14th. The company reported $47.49 earnings per share for the quarter. The firm had revenue of $2.62 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

Hedge Funds Weigh In On Moolec Science

An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new stake in shares of Moolec Science SA (NASDAQ:MLEC) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent reporting period. 0.07% of the stock is owned by institutional investors and hedge funds.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.